Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Diacerein vs ARTRODAR in Healthy Thai Volunteers
NCT06308068Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jul 2024
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 1, randomised, open-label trial of diacerein in osteoarthritis (OA) (2 arms), sponsored by International Bio Service. Primary endpoints: Maximum Plasma Concentration at 36 hours and Area Under the Curve at 36 hours. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
diacerein
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06308068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06308068.